Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia

Eliano Pio Navarese,Michalina Kołodziejczak,Volker Schulze,Paul A. Gurbel,Udaya S. Tantry,Yingfeng Lin,Maximilian Brockmeyer,David E. Kandzari,Julia Maria Kubica,Ralph B. DAgostino,Jacek Kubica,Massimo Volpe,Stefan Agewall,Dean J. Kereiakes,Malte Kelm

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia

2020

Eliano Pio Navarese
Michalina Kołodziejczak
Volker Schulze
Paul A. Gurbel
Udaya S. Tantry
Yingfeng Lin
Maximilian Brockmeyer
David E. Kandzari
Julia Maria Kubica
Ralph B. DAgostino
Jacek Kubica
Massimo Volpe
Stefan Agewall
Dean J. Kereiakes
Malte Kelm

This meta-analysis of 24 phase 2 and phase 3 trials summarizes important data about the efficacy and safety of PCSK9 inhibitors in adults with hypercholesterolemia. PCSK9 antibodies produced profou...

Keywords:

Internal medicine
Monoclonal antibody
Subtilisin
Antibody
Proprotein convertase
PCSK9
PCSK9 Inhibitors
Cholesterol
Pharmacology
Medicine
Cardiology
Kexin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations